Possible mechanisms underlying fatty liver in a rat model of male hypogonadism

A protective role for testosterone

Hussein F. Sakr, Abdelaziz M. Hussein, Elsayed A. Eid, Mahmoud AlKhateeb

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims: To investigate the effects of testosterone (Test) deficiency and testosterone replacement therapy (TRT) on the development of non-alcoholic fatty liver disease (NAFLD) and associated peripheral insulin resistance (IR) in male rats and to illustrate the underlying mechanisms of action. Materials and methods: male Sprague Dawley rats were divided into 3 groups as follows: 1) sham-operated group (n = 11), 2) ORCD-induced group (n = 9) exposed to orchidectomy (ORCD), achieved by complete surgical removal of testicles, and 3) ORCD + Test treated group (n = 10) (11 ng/mL Test propionate, 3x/week, S.C.). Results: Data revealed significant increases in final body, liver, visceral and subcutaneous fats weights with significant increases in fasting plasma glucose and insulin levels and HOMA-IR. Additionally, ORCD rats had higher UAC for measured glucose levels and insulin levels during OGTT and higher AUC for measured glucose levels during ITT. Interesting, higher serum and hepatic levels of TGs and CHOL and higher serum levels of LDL were seen in ORCD-induced rats. Mechanistically, significant increases in mRNA levels of SREBP-1, SREBP-2, ACC-1, FAS, HMGCOAR and HMGCOAS with significant increases in protein levels of both precursor and mature SREBP-1 and SREBP-2, PPAR-α, p-PPAR-α, CPT-1 and UCP-2 and significant lower protein levels p-AMPK and p-ACC-1 were detected in livers of ORCD rats. Test administration to ORCD-induced rats significantly ameliorated all of the above mentioned biochemical endpoints and reversed the effect of ORCD on mRNA and protein levels of these targets. In conclusion, Test deficiency could be an independent risk factor for the development of NAFLD by upregulation of lipid synthesis and disturb fatty acids oxidation whereas Test therapy is a protective strategy.

Original languageEnglish
Pages (from-to)21-30
Number of pages10
JournalSteroids
Volume135
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Eunuchism
Orchiectomy
Fatty Liver
Liver
Testosterone
Rats
Insulin
Peroxisome Proliferator-Activated Receptors
Glucose
Insulin Resistance
Testosterone Propionate
Messenger RNA
Proteins
AMP-Activated Protein Kinases
Intra-Abdominal Fat
Subcutaneous Fat
Fatty Acids
Glucose Tolerance Test
Serum
Fats

Keywords

  • Fatty liver
  • Male hypogonadism
  • Orchidectomy
  • Testosterone

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology
  • Pharmacology
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Possible mechanisms underlying fatty liver in a rat model of male hypogonadism : A protective role for testosterone. / Sakr, Hussein F.; Hussein, Abdelaziz M.; Eid, Elsayed A.; AlKhateeb, Mahmoud.

In: Steroids, Vol. 135, 01.07.2018, p. 21-30.

Research output: Contribution to journalArticle

Sakr, Hussein F. ; Hussein, Abdelaziz M. ; Eid, Elsayed A. ; AlKhateeb, Mahmoud. / Possible mechanisms underlying fatty liver in a rat model of male hypogonadism : A protective role for testosterone. In: Steroids. 2018 ; Vol. 135. pp. 21-30.
@article{55f01abd21644b2baffef2dd56028fcb,
title = "Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone",
abstract = "Aims: To investigate the effects of testosterone (Test) deficiency and testosterone replacement therapy (TRT) on the development of non-alcoholic fatty liver disease (NAFLD) and associated peripheral insulin resistance (IR) in male rats and to illustrate the underlying mechanisms of action. Materials and methods: male Sprague Dawley rats were divided into 3 groups as follows: 1) sham-operated group (n = 11), 2) ORCD-induced group (n = 9) exposed to orchidectomy (ORCD), achieved by complete surgical removal of testicles, and 3) ORCD + Test treated group (n = 10) (11 ng/mL Test propionate, 3x/week, S.C.). Results: Data revealed significant increases in final body, liver, visceral and subcutaneous fats weights with significant increases in fasting plasma glucose and insulin levels and HOMA-IR. Additionally, ORCD rats had higher UAC for measured glucose levels and insulin levels during OGTT and higher AUC for measured glucose levels during ITT. Interesting, higher serum and hepatic levels of TGs and CHOL and higher serum levels of LDL were seen in ORCD-induced rats. Mechanistically, significant increases in mRNA levels of SREBP-1, SREBP-2, ACC-1, FAS, HMGCOAR and HMGCOAS with significant increases in protein levels of both precursor and mature SREBP-1 and SREBP-2, PPAR-α, p-PPAR-α, CPT-1 and UCP-2 and significant lower protein levels p-AMPK and p-ACC-1 were detected in livers of ORCD rats. Test administration to ORCD-induced rats significantly ameliorated all of the above mentioned biochemical endpoints and reversed the effect of ORCD on mRNA and protein levels of these targets. In conclusion, Test deficiency could be an independent risk factor for the development of NAFLD by upregulation of lipid synthesis and disturb fatty acids oxidation whereas Test therapy is a protective strategy.",
keywords = "Fatty liver, Male hypogonadism, Orchidectomy, Testosterone",
author = "Sakr, {Hussein F.} and Hussein, {Abdelaziz M.} and Eid, {Elsayed A.} and Mahmoud AlKhateeb",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.steroids.2018.04.004",
language = "English",
volume = "135",
pages = "21--30",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Possible mechanisms underlying fatty liver in a rat model of male hypogonadism

T2 - A protective role for testosterone

AU - Sakr, Hussein F.

AU - Hussein, Abdelaziz M.

AU - Eid, Elsayed A.

AU - AlKhateeb, Mahmoud

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Aims: To investigate the effects of testosterone (Test) deficiency and testosterone replacement therapy (TRT) on the development of non-alcoholic fatty liver disease (NAFLD) and associated peripheral insulin resistance (IR) in male rats and to illustrate the underlying mechanisms of action. Materials and methods: male Sprague Dawley rats were divided into 3 groups as follows: 1) sham-operated group (n = 11), 2) ORCD-induced group (n = 9) exposed to orchidectomy (ORCD), achieved by complete surgical removal of testicles, and 3) ORCD + Test treated group (n = 10) (11 ng/mL Test propionate, 3x/week, S.C.). Results: Data revealed significant increases in final body, liver, visceral and subcutaneous fats weights with significant increases in fasting plasma glucose and insulin levels and HOMA-IR. Additionally, ORCD rats had higher UAC for measured glucose levels and insulin levels during OGTT and higher AUC for measured glucose levels during ITT. Interesting, higher serum and hepatic levels of TGs and CHOL and higher serum levels of LDL were seen in ORCD-induced rats. Mechanistically, significant increases in mRNA levels of SREBP-1, SREBP-2, ACC-1, FAS, HMGCOAR and HMGCOAS with significant increases in protein levels of both precursor and mature SREBP-1 and SREBP-2, PPAR-α, p-PPAR-α, CPT-1 and UCP-2 and significant lower protein levels p-AMPK and p-ACC-1 were detected in livers of ORCD rats. Test administration to ORCD-induced rats significantly ameliorated all of the above mentioned biochemical endpoints and reversed the effect of ORCD on mRNA and protein levels of these targets. In conclusion, Test deficiency could be an independent risk factor for the development of NAFLD by upregulation of lipid synthesis and disturb fatty acids oxidation whereas Test therapy is a protective strategy.

AB - Aims: To investigate the effects of testosterone (Test) deficiency and testosterone replacement therapy (TRT) on the development of non-alcoholic fatty liver disease (NAFLD) and associated peripheral insulin resistance (IR) in male rats and to illustrate the underlying mechanisms of action. Materials and methods: male Sprague Dawley rats were divided into 3 groups as follows: 1) sham-operated group (n = 11), 2) ORCD-induced group (n = 9) exposed to orchidectomy (ORCD), achieved by complete surgical removal of testicles, and 3) ORCD + Test treated group (n = 10) (11 ng/mL Test propionate, 3x/week, S.C.). Results: Data revealed significant increases in final body, liver, visceral and subcutaneous fats weights with significant increases in fasting plasma glucose and insulin levels and HOMA-IR. Additionally, ORCD rats had higher UAC for measured glucose levels and insulin levels during OGTT and higher AUC for measured glucose levels during ITT. Interesting, higher serum and hepatic levels of TGs and CHOL and higher serum levels of LDL were seen in ORCD-induced rats. Mechanistically, significant increases in mRNA levels of SREBP-1, SREBP-2, ACC-1, FAS, HMGCOAR and HMGCOAS with significant increases in protein levels of both precursor and mature SREBP-1 and SREBP-2, PPAR-α, p-PPAR-α, CPT-1 and UCP-2 and significant lower protein levels p-AMPK and p-ACC-1 were detected in livers of ORCD rats. Test administration to ORCD-induced rats significantly ameliorated all of the above mentioned biochemical endpoints and reversed the effect of ORCD on mRNA and protein levels of these targets. In conclusion, Test deficiency could be an independent risk factor for the development of NAFLD by upregulation of lipid synthesis and disturb fatty acids oxidation whereas Test therapy is a protective strategy.

KW - Fatty liver

KW - Male hypogonadism

KW - Orchidectomy

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=85046072245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046072245&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2018.04.004

DO - 10.1016/j.steroids.2018.04.004

M3 - Article

VL - 135

SP - 21

EP - 30

JO - Steroids

JF - Steroids

SN - 0039-128X

ER -